DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Editor in the Journal of Diabetes Science and Technology. The study is titled “Digital Therapeutics for Type 2 Diabetes: Incorporating Coaching Support and Validating Digital Monitoring.” People living with Type […]

RNA cell therapy is a new class of advanced therapies now in clinical trials to treat an array of diseases in and beyond oncology. These therapies combine the best features of two therapeutics modalities, conventional RNA therapy and cell therapy, while avoiding key drawbacks. With RNA cell therapy, there is no need to package RNA […]

OpRegen led to restoration of retinal tissue for 75% of patients with dry AMD and geographic atrophy who received the treatment across a wide area of atrophy. OpRegen, which consists of allogeneic retinal pigment epithelial (RPE) cells, led to restoration of retinal tissue for 3 out of 4 patients (75%) with dry age-related macular degeneration […]